In agreement with other studies, we showed that VDAC2 is crucial for cellular calcium cycling and normal cardiac functioning, thereby making it a promising therapeutic target for DCM and chronic HF6,15. This evidence concerns the gene VDAC2 and familial dilated cardiomyopathy.